Pharmaceutical Technology

OCTOBER 5, 2022

These, along with other similar claims, meant Biogen owed potential damages of $1,036,900,151 to the US and the various States, as per court documents. In 2005, Biogen withdrew Tysabri from the market following a clinical trial that resulted in two participants contracting progressive multifocal leukoencephalopathy (PML).

Documentation 59

Documentation Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JULY 6, 2021

The new figures – from the BioIndustry Association and Clarivate – were dominated by more than £1 billion in venture capital funding for UK biotech and life sciences companies, headlined by DNA sequencing company Oxford Nanopore’s £195 million raise in May that was just shy of the £205 million record set by Immunocore in 2005.

Documentation 141

Documentation Vaccines 141

European Pharmaceutical Review

NOVEMBER 24, 2022

These include Meditag serialised hologram labels, first introduced in 2005 and found on all registered medicines in Malaysia to help pharmacists and inspectors detect unauthorised and counterfeit product. ” Several branded medicines are available that feature holograms on the packaging or in the blister pack.

Packaging 111

Packaging Labelling Documentation Dosage 111

European Pharmaceutical Review

APRIL 14, 2025

Master file the manufacturing dossier in which the main regulatory documents are collected and to which all subordinate sites refer. Under the Blood Safety and Quality Regulations 2005. Other manufacturing sites are subordinate to the control site and do not need their own separate regulatory approvals. One file per product.

Hospitals 52

Hospitals Documentation Packaging Communication 52

Quality Matters

SEPTEMBER 15, 2023

FDA Guidance on Testing High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol (Disclaimer: The article below includes a discussion of key points of the guidance document. It is not the guidance document, nor it is an alternative to the guidance document. The guidance document is available here: [link].)

Documentation 52

Documentation Compounding Pharmaceutical Manufacturing 52

Pharma in Brief

JANUARY 10, 2024

The Guidance was last updated in 2005. The Court now requires a declaration identifying documents with AI-generated content that are prepared for the purpose of litigation and submitted to the Court. The Guidance outlines the factors that contribute to rendering a message or activity promotional in nature.

Drug Pricing 52

Drug Pricing Documentation Biosimilars Vaccines 52

European Pharmaceutical Review

DECEMBER 19, 2023

7 The additional substantial economic benefits that flow from room-temperature storability have also been thoroughly documented. This requires the development of technologies to rapidly produce effective, safe, stable vaccines that can be manufactured and distributed quickly. Maillard Reaction and Drug Stability. Woodhead Publishing.

Vaccines 111

Vaccines Communication Immunization Immunity 111

The Thyroid Pharmacist

MARCH 31, 2023

I had always been an outspoken, level-headed and calm person, but sometime in 2005, something called “new-onset anxiety” rocked my world. Anxiety was one of the most challenging and disempowering symptoms I experienced when I was first diagnosed with Hashimoto’s. I was scared. I couldn’t deal with life.

Immunity 105

Immunity Immunization Dosage Documentation 105

Board Vitals - Pharmacist

JANUARY 6, 2023

A one-time requirement of six credits for cultural competence is to be completed in addition to the 100 hour requirement for physicians licensed before March 24, 2005. Of the 40 AMA PRA Category 1 Credits , 2 shall be related to End-of-Life care. These credits may be included if licensed after this date.

Controlled Substances 59

Controlled Substances Documentation 59

Pharmaceutical Technology

OCTOBER 28, 2022

Quality by design (QbD) is a concept introduced into the pharmaceutical regulatory lexicon in 2005. QbD principles are woven into regulatory guidance documents, primarily guidances Q8 to Q11 of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

Biosimilars 52

Biosimilars Vaccines Drug Development Documentation 52

Pharmaceutical Technology

APRIL 27, 2023

Joe Makowiecki, business and product development leader for Enterprise Solutions at Cytiva, says the situation now reminds him of when single-use technology was in its nascency for monoclonal antibody (mAb) manufacture in 2005. “We There was a lot of cynicism and questions, like: ‘Why would you want to use single use?

Vaccines 52

Vaccines Drug Development Documentation Communication 52

FDA Law Blog: Biosimilars

NOVEMBER 11, 2024

Along with the proposed order, FDA issued as a supporting document the “ Scientific Review Supporting Proposed Administrative Order ” in which it describes the scientific data on the efficacy, pharmacology, and safety of oral PE underlying its determination to issue the proposed order. a); OTC Monograph M012: § M012.20.

Pharmacy Management 111

Pharmacy Management Dosage Documentation 111

The Thyroid Pharmacist

FEBRUARY 10, 2023

A few years ago, I had a few clients with documented elevations in prolactin, and I have seen that lowering prolactin levels can help with reducing thyroid antibodies. Studies have, however, documented that bromocriptine, a medication used to lower prolactin levels, can reduce flares in lupus, another autoimmune condition.

Dosage 98

Dosage Documentation Diabetes Labelling 98

The Thyroid Pharmacist

JANUARY 20, 2023

Holy Basil ( Ocimum sanctum ) The anti-inflammatory effects of holy basil (also known as tulsi) have been documented in many in vitro and in vivo studies. Epub 2005 Oct 7; Costa CA, Tanimoto A, Quaglio AE, et al. Int J Ayurveda Res. 2010;1(1):37-40. doi:10.4103/0974-7788.59942 [57] Pinello KC, Fonseca Ede S, Akisue G, et al.

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Diabetes Immunity Immunization 98